Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2400046	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	License Renew	2024-07-18		GlaxoSmithKline Biologicals SA			view
JYSZ2400045	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	License Renew	2024-07-18		GlaxoSmithKline Biologicals SA			view
CYSB2300231	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-12-09		Shenzhen Kangtai Biological Products Co Ltd			view
CYSB2300074	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-03-30		Shenzhen Kangtai Biological Products Co Ltd			view
JYSB2300038	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-02-23		GlaxoSmithKline Biologicals SA			view
JYSB2300037	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-02-23		GlaxoSmithKline Biologicals SA			view
CYSB2300040	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-02-13		Beijing Institute of Biological Products Co Ltd			view
CYSB2300039	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-02-13		Beijing Institute of Biological Products Co Ltd			view
CYSB2300038	重组乙型肝炎疫苗（酿酒酵母）	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-02-13		Beijing Institute of Biological Products Co Ltd			view
JYSB2300006	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-01-14		GlaxoSmithKline Biologicals SA			view
JYSB2300007	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2023-01-14		GlaxoSmithKline Biologicals SA			view
JTS2200063	重组乙型肝炎疫苗（酿酒酵母）参考品（内控）		Other	Biological Products	Disposable Import Drug Application	2022-08-18					view
JTS2200064	重组乙型肝炎疫苗（酿酒酵母）标准品		Other	Biological Products	Disposable Import Drug Application	2022-08-18					view
JYSB2200113	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2022-07-02		GlaxoSmithKline Biologicals SA			view
JYSB2200112	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2022-07-02		GlaxoSmithKline Biologicals SA			view
JYSB2101077	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2021-07-05		GlaxoSmithKline Biologicals SA			view
JYSB2101078	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2021-07-05		GlaxoSmithKline Biologicals SA			view
JYSB2101075	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2021-07-02		GlaxoSmithKline Biologicals SA			view
JYSB2101076	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2021-07-02		GlaxoSmithKline Biologicals SA			view
JYSB2100055	重组乙型肝炎疫苗(酿酒酵母)	Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae)	Injection	Biological Products	Supplementary Application	2021-02-23	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2021-02-22	view